Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61P - Specific therapeutic activity of chemical compounds or medicinal preparations › A61P 25 - Drugs for disorders of the nervous system
Patents for A61P 25 - Drugs for disorders of the nervous system (183,225)
06/2010
06/23/2010CN101744958A Powdered medicine for treating epilepsy
06/23/2010CN101744951A Lumbar intervertebral disc protrusion rehabilitation pill
06/23/2010CN101744940A Topical ointment of traditional Chinese medicine and preparation method thereof used for curing pains on head and face
06/23/2010CN101744918A Medicine for treating generalized anxiety and preparation method thereof
06/23/2010CN101744917A Applications of Chinese medicinal composition to preparation of medicament for improving hypertension nervous symptoms
06/23/2010CN101744906A Applications of Chinese medicinal composition to preparation of medicament for treating facial paralysis
06/23/2010CN101744893A Preparation method of fleece-flower root swelling product
06/23/2010CN101744886A Method for extracting high-purity schisandra total lignan
06/23/2010CN101744877A Selfheal quality control method
06/23/2010CN101744876A Preparation for refreshing brain and invigorating spirit
06/23/2010CN101744863A Persimmon leaf extract preparation, preparing method thereof and application thereof
06/23/2010CN101744858A New use of wind-dispelling, collateral-activating Chinese herbal medicines including scorpion, angelica dahurica and radix sileris for treatment of headache
06/23/2010CN101744852A Preparation method of acanthopanax effervescent tablet and products thereof
06/23/2010CN101744847A Agaricus compound polysaccharide capsule preparation method
06/23/2010CN101744828A Usage of forsythiaside for preparing medicine treating senile dementia
06/23/2010CN101744816A Hyoscine butylbromide compound preparation and preparation method thereof
06/23/2010CN101744811A Bulleyaconitine A and adrenaline compounded sterile powder for injection
06/23/2010CN101744810A Bulleyaconitine A and lidocaine compounded sterile powder for injection
06/23/2010CN101744787A Controlled release composite containing vinpocetine
06/23/2010CN101744779A Clozapine orally disintegrating tablet preparation and formula thereof
06/23/2010CN101744774A Method for preparing ginkgolide B lyophilized powder injection
06/23/2010CN101744765A Bulleyaconitine A multivesicular liposome and preparation method thereof
06/23/2010CN101744487A Chinese medicinal tea health care pillow
06/23/2010CN101744268A Traditional Chinese medicine health food with function of improving sleep and preparation method thereof
06/23/2010CN101744249A Sober-up health congee and preparation method thereof
06/23/2010CN101744248A Instant porridge with effect of relieving insomnia
06/23/2010CN101744074A Method for manufacturing sleep-supporting flower, grass and tea combination
06/23/2010CN101743963A Mosquito repellent and preparation method thereof
06/23/2010CN101307025B Chuanxiong alcohol carnitine ester compounds
06/23/2010CN101215283B Secalonic acid A compound and its preparing method and application in preparing neuron cell protection medicament
06/23/2010CN101168025B Medicine composition for preventing and treating senile dementia
06/23/2010CN101085306B Oral administration medicament for treating depression
06/23/2010CN101072762B Phenyl-piperazin methanone derivatives
06/23/2010CN101029064B Bean-curd pectin analogues, and its use in preparation of medicine for preventing senile dementia
06/23/2010CN101020659B 9-aminoalkylamido-1-azabenznthrone derivative and its synthesis and application
06/22/2010US7741452 produced by introducing amino acid mutation(s) so that no glycosylation take place at at least one glycosylation site of hepatocyte growth factor; more stable in the blood circulation
06/22/2010US7741436 Injecting the tripeptide, Lys-Asp-Ile, derived from the neurite outgrowth-promoting domain of laminin-1, into the epidural space of the spine to regenerate the tissue
06/22/2010US7741349 Neuroprotectants; treatment of neuropathies resulting from chemtherapeutic agents used in the treatment of HIV and proliferative disease such as cancer and treatment of inflammatory diseases; neurodegenerative diseases; enzyme inhibitors for seine/threonine kinases, phosphatases; Alzheimer'
06/22/2010US7741343 6H-oxazolo[4,5 e]indole derivatives as nicotinic acetylcholine receptor ligands and/or serotonergic ligands
06/22/2010US7741342 Water-soluble thalidomine derivatives
06/22/2010US7741335 administering nontoxic, preferential and potent c-kit ligand inhibitors such as imatinib, to humans for treatment of inflammatory diseases such as rheumatoid arthritis
06/22/2010US7741329 such as 1-{(S)-2-[(5-Bromo-pyrimidin-2-ylamino)-methyl]-piperidin-1-yl}-1-quinolin-2-yl-methanone, used as human orexin receptor antagonist, for the treatment of obesity and insomnia
06/22/2010US7741328 Treating inflammatory diseases such as rheumatoid arthritis, multiple sclerosis or Crohn's disease; Very Late Antigen-4 (VLA-4), also called alpha 4 beta 1 integrin; N-(sulfonamido-substituted pyrimidyl, pyridyl or pyrazyl)-L-4-(N,N-dimethylcarbamyloxy)phenylalanine compounds
06/22/2010US7741320 6,7-dichloro-4-cyclopropyl-3,4-dihydro-2H-1,2,4-benzothiadiazine 1,1-dioxide, used as AMPA receptor modulators for the treatment of anxiety, depression, Parkinson's disease, Pick's disease, Huntington's chorea, Korsakoff's disease and schizophrenia
06/22/2010US7741318 used for treating central nervous system diseases such as depression, cognitive diseases and neurodegenerative diseases such as Parkinson's disease, alzheimer's disease or psychoses, and stroke
06/22/2010US7741316 Pharmacological uses of azetidine derivatives
06/22/2010US7741312 Benzylaminosulfonic Acid or portion or analogue linked to a carbohydrate or glycomimetic for modulating processes mediated by selectin binding such as autoimmune and inflammatory diseases, shock and reperfusion injuries
06/22/2010US7741289 Substituted azetidinone compounds, processes for preparing the same, formulations and uses thereof
06/22/2010US7741278 Modified proteins, designer toxins, and methods of making thereof
06/22/2010US7741078 Heparin-binding protein modified with heparan sulfate sugar chains, process for producing the same and pharmaceutical compositions containing the same
06/22/2010US7740854 Treatment of macrophage mediated disease
06/22/2010CA2586538C Nitroxy steroids
06/22/2010CA2541131C Derivatives of piperazine, process for their preparation and pharmaceutical compositions containing them
06/22/2010CA2492161C New derivatives of fluorinated benzothiadiazines, the process for preparing them and the pharmaceutical compounds that contain them
06/22/2010CA2480409C Novel pyrazolo[4,3-d]pyrimidines, processes for their preparation and methods for therapy
06/22/2010CA2469225C Citric acid salt of 4-(3,4-dichlorophenyl)-2-[2-(4-methylpiperazin-1-yl)-benzylidene]-thiomorpholin-3-one and pharmaceutical compositions thereof
06/22/2010CA2444489C Benzimidazolone compounds
06/22/2010CA2444198C Nociceptin analogs
06/22/2010CA2443938C Spiroindene and spiroindane compounds as opioid ligands useful for treating pain
06/22/2010CA2434067C Materials and methods relating to protein aggregation in neurodegenerative disease
06/22/2010CA2428603C Prevention of development of dyskinesias with an alfa 2-adrenoceptor antagonist
06/22/2010CA2411716C 1,3,8-triaza-spiro [4.5] decan derivatives
06/22/2010CA2406177C 8.beta.-hydrocarbyl-substituted estratrienes as selectively active estrogens
06/22/2010CA2389553C Heteroaryl-diazabicycloalkanes
06/22/2010CA2382355C Oxazole and thiazole derivatives as neurotrophin production/secretion promoting agent
06/22/2010CA2374346C Inhibitors of memapsin 2 and use thereof
06/22/2010CA2295577C Method for recognizing and determining gnrh receptors and the use of gnrh agonists and gnrh antagonists and other gnrh receptor ligands for the treatment with gnrh receptors of tumors originating in the brain and/or nervous system and/or meninges and/or of kaposi sarcoma
06/22/2010CA2190943C Pharmaceutical compositions comprising an opiate antagonist and calcium salts, their use for the treatment of endorphin-mediated pathologies
06/17/2010WO2010068877A2 Compounds that bind oxysterol binding proteins, and methods of use thereof
06/17/2010WO2010068750A2 Compositons and method for treatment of mood and cognitive impairments
06/17/2010WO2010068483A2 Mlk inhibitors and methods of use
06/17/2010WO2010068480A1 Deuterated derivatives of dimeboline
06/17/2010WO2010068173A1 L-lysine for improving normal cognitive functions
06/17/2010WO2010067594A1 Hexahydropyrroloindole derivative
06/17/2010WO2010067069A1 Compounds for use in the treatment of pain
06/17/2010WO2010067010A2 Derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/17/2010WO2010067008A2 Bicyclic derivatives of morphine-6-glucuronide, preparation method thereof and use of same in therapeutics
06/17/2010WO2010067007A2 Synthesis of morphine-6-glucuronide or one of the derivatives thereof
06/17/2010WO2010066931A1 Alpha-derivatives of cis-monounsaturated fatty acids intended for use as a drug
06/17/2010WO2010066852A1 Composition comprising isoflavones
06/17/2010WO2010066815A2 Encapsulating system for cest imaging with chelate q greater than or equal to 2
06/17/2010WO2010066658A1 Compounds which potentiate the ampa receptor and uses thereof in medicine
06/17/2010WO2010066629A2 Novel azaindoles
06/17/2010WO2010066380A1 Triaryl-sulphonium compounds, kit and methods for labeling positron emitting isotopes
06/17/2010WO2010066357A1 Benzothiazole amides for detection of amyloid beta
06/17/2010WO2010066253A1 Selective inhibitors of excitatory amino acid transporter subtype 1 (eaat1 /glast)
06/17/2010WO2010066239A1 Inhibitors of dimethylarginine dimethylaminohydrolase
06/17/2010WO2010066159A1 A preparation method of venlafaxine sustained release formulation
06/17/2010WO2010066125A1 A short peptide, preparation and uses thereof
06/17/2010WO2010044981A3 Benzoquinoline inhibitors of vesicular monoamine transporter 2
06/17/2010WO2010031043A3 Reducing or preventing neuroinflammation or neurotoxicity
06/17/2010WO2010025931A3 Pharmaceutical combination of 3- (3-dimethylamino-1-ethyl-2 -methyl-propyl) - phenol and an antiepileptic
06/17/2010WO2010022055A3 1, 3, 5 -triaz ine derivatives useful in the treatment of chronic pain disorders
06/17/2010WO2010017216A3 Mesenchymal stromal cell populations and methods of isolating and using same
06/17/2010WO2008128740A8 Titration of tapentadol
06/17/2010US20100152812 Systems and methods for promoting nerve recognition
06/17/2010US20100152446 Piperidine Derivatives
06/17/2010US20100152303 Agents and method for increasing brain chaperonin levels
06/17/2010US20100152296 Photopolymerization material for gums isolation
06/17/2010US20100152284 Prevention and reversal of chemotherapy-induced peripheral neuropathy
1 ... 464 465 466 467 468 469 470 471 472 473 474 475 476 477 478 479 480 481 482 483 484 ... 1833